{"id":"W4403665664","doi":"10.1093/bjd/ljae402","title":"Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded active-controlled comparative clinical study over 52 weeks","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Amgen","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Randomized controlled trial; Clinical endpoint; Adverse effect; Internal medicine; Psoriasis; Randomization; Gastroenterology; Dermatology; Adalimumab; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001269008,0.0002661756,0.00251643,0.0002279705,0.0001205974,0.00005494701,0.0003264502,0.000413294,0.00009522185],"category_scores_gemma":[0.0003602468,0.000166557,0.0003235513,0.0003622419,0.0006341048,0.0001378567,0.0001319943,0.001162272,0.000002863143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003935134,"about_ca_system_score_gemma":0.000208081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003987394,"about_ca_topic_score_gemma":0.0001542916,"domain_scores_codex":[0.9941382,0.003278682,0.001750303,0.0003629157,0.0001295931,0.0003402611],"domain_scores_gemma":[0.996721,0.00217681,0.0005488913,0.0001890957,0.0002895843,0.00007458192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9659307,0.00235965,0.01948419,0.0000395231,0.004483787,0.0003371954,0.0009152445,0.0000251746,0.00008481951,0.0002202321,0.001272518,0.004846966],"study_design_scores_gemma":[0.8218519,0.00102928,0.170919,0.0006421021,0.001015309,0.002495602,0.0003785008,0.00008345824,0.0007695205,0.0001648538,0.0003753629,0.0002751803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929155,0.002411777,0.0002173344,0.001145264,0.0007384775,0.002379774,0.00004770684,0.00001106873,0.000133125],"genre_scores_gemma":[0.9991742,0.0001800247,0.0002644538,0.0002660656,0.00002845415,0.00002709271,0.000003051046,0.00001648244,0.00004014501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1514347,"threshold_uncertainty_score":0.6791998,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02733701388696473,"score_gpt":0.3263798375749371,"score_spread":0.2990428236879724,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}